Iovance Biotherapeutics, Inc. (IOVA)
14.62
+1.31
(+9.84%)
USD |
NASDAQ |
Oct 09, 16:00
14.62
0.00 (0.00%)
After-Hours: 20:00
Iovance Biotherapeutics Free Cash Flow (Quarterly) : -66.28M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -66.28M |
| March 31, 2026 | -78.68M |
| December 31, 2025 | -61.88M |
| September 30, 2025 | -89.55M |
| June 30, 2025 | -74.91M |
| March 31, 2025 | -109.90M |
| December 31, 2024 | -77.46M |
| September 30, 2024 | -61.26M |
| June 30, 2024 | -98.87M |
| March 31, 2024 | -126.45M |
| December 31, 2023 | -87.50M |
| September 30, 2023 | -87.66M |
| June 30, 2023 | -103.47M |
| March 31, 2023 | -105.48M |
| December 31, 2022 | -80.69M |
| September 30, 2022 | -65.04M |
| June 30, 2022 | -82.21M |
| March 31, 2022 | -85.24M |
| December 31, 2021 | -61.42M |
| September 30, 2021 | -67.38M |
| June 30, 2021 | -63.62M |
| March 31, 2021 | -73.10M |
| December 31, 2020 | -86.03M |
| September 30, 2020 | -58.36M |
| June 30, 2020 | -41.61M |
| Date | Value |
|---|---|
| March 31, 2020 | -65.93M |
| December 31, 2019 | -57.25M |
| September 30, 2019 | -43.42M |
| June 30, 2019 | -35.23M |
| March 31, 2019 | -29.91M |
| December 31, 2018 | -31.84M |
| September 30, 2018 | -28.39M |
| June 30, 2018 | -24.34M |
| March 31, 2018 | -17.87M |
| December 31, 2017 | -20.91M |
| September 30, 2017 | -21.71M |
| June 30, 2017 | -17.52M |
| March 31, 2017 | -19.60M |
| December 31, 2016 | -12.90M |
| September 30, 2016 | -12.93M |
| June 30, 2016 | -3.802M |
| March 31, 2016 | -4.554M |
| December 31, 2015 | -6.73M |
| September 30, 2015 | -3.916M |
| June 30, 2015 | -4.637M |
| March 31, 2015 | -4.241M |
| December 31, 2014 | -4.741M |
| September 30, 2014 | -1.889M |
| June 30, 2014 | -1.324M |
| March 31, 2014 | -2.271M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| AVITA Medical, Inc. | -3.742M |
| Halozyme Therapeutics, Inc. | 236.72M |
| Amgen, Inc. | 3.489B |
| CareDx, Inc. | 28.75M |
| Xencor, Inc. | -56.20M |